Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia
暂无分享,去创建一个
K. Weinfurt | J. Radich | R. Larson | Li Lin | Mei‐jie Zhang | J. Cortes | M. Deininger | M. Wadleigh | R. Silver | J. Pinilla-Ibarz | M. Mauro | K. Flynn | Joseph O. Moore | C. Schiffer | N. Shah | E. Ritchie | James E. Thompson | V. Oehler | E. Atallah | M. Horowitz | Jessica Guhl